Russia’s focus on domestic pharma production could shield it from sanctions’ effects
Pharmaceutical Technology
JULY 4, 2022
Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. Most pharma sites operating in Russia are owned by domestic companies. Roszdravnadzor was founded by Vladimir Putin in 2004.
Let's personalize your content